164 related articles for article (PubMed ID: 15668707)
41. Relationship Between the Expression of O
Vitellius C; Eymerit-Morin C; Luet D; Fizanne L; Foubert F; Bertrais S; Rousselet MC; Caroli-Bosc FX
Clin Drug Investig; 2017 Jul; 37(7):669-677. PubMed ID: 28421382
[TBL] [Abstract][Full Text] [Related]
42. Overexpression of MutL homolog 1 and MutS homolog 2 proteins have reversed prognostic implications for stage I-II colon cancer patients.
Huang SC; Huang SF; Chen YT; Chang Y; Chiu YT; Chang IC; Wu HI; Chen JS
Biomed J; 2017 Feb; 40(1):39-48. PubMed ID: 28411881
[TBL] [Abstract][Full Text] [Related]
43. Role of Autophagy and Apoptosis in Non-Small-Cell Lung Cancer.
Liu G; Pei F; Yang F; Li L; Amin AD; Liu S; Buchan JR; Cho WC
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208579
[TBL] [Abstract][Full Text] [Related]
44. Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer.
Mármol I; Sánchez-de-Diego C; Pradilla Dieste A; Cerrada E; Rodriguez Yoldi MJ
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106826
[TBL] [Abstract][Full Text] [Related]
45. KRAS and TP53 mutations in inflammatory bowel disease-associated colorectal cancer: a meta-analysis.
Du L; Kim JJ; Shen J; Chen B; Dai N
Oncotarget; 2017 Mar; 8(13):22175-22186. PubMed ID: 28077799
[TBL] [Abstract][Full Text] [Related]
46. Clinical Relevance and Molecular Phenotypes in Gastric Cancer, of TP53 Mutations and Gene Expressions, in Combination With Other Gene Mutations.
Park S; Lee J; Kim YH; Park J; Shin JW; Nam S
Sci Rep; 2016 Oct; 6():34822. PubMed ID: 27708434
[TBL] [Abstract][Full Text] [Related]
47. Prognostic significance of survivin in rectal cancer patients treated with surgery and postoperative concurrent chemo-radiation therapy.
Yu JI; Lee H; Park HC; Choi DH; Choi YL; Do IG; Kim HC; Lee WY; Yun SH; Cho YB; Huh JW; Park YA; Park YS; Park JO; Kim ST; Park W
Oncotarget; 2016 Sep; 7(38):62676-62686. PubMed ID: 27391438
[TBL] [Abstract][Full Text] [Related]
48. TP53 Mutational Status and Prediction of Benefit from Adjuvant 5-Fluorouracil in Stage III Colon Cancer Patients.
Kandioler D; Mittlböck M; Kappel S; Puhalla H; Herbst F; Langner C; Wolf B; Tschmelitsch J; Schippinger W; Steger G; Hofbauer F; Samonigg H; Gnant M; Teleky B; Kührer I;
EBioMedicine; 2015 Aug; 2(8):825-30. PubMed ID: 26425688
[TBL] [Abstract][Full Text] [Related]
49. Wild-type APC predicts poor prognosis in microsatellite-stable proximal colon cancer.
Jorissen RN; Christie M; Mouradov D; Sakthianandeswaren A; Li S; Love C; Xu ZZ; Molloy PL; Jones IT; McLaughlin S; Ward RL; Hawkins NJ; Ruszkiewicz AR; Moore J; Burgess AW; Busam D; Zhao Q; Strausberg RL; Lipton L; Desai J; Gibbs P; Sieber OM
Br J Cancer; 2015 Sep; 113(6):979-88. PubMed ID: 26305864
[TBL] [Abstract][Full Text] [Related]
50. Germline and somatic genetic predictors of pathological response in neoadjuvant settings of rectal and esophageal cancers: systematic review and meta-analysis.
Salnikova LE; Kolobkov DS
Pharmacogenomics J; 2016 Jun; 16(3):249-65. PubMed ID: 26122021
[TBL] [Abstract][Full Text] [Related]
51. Determination of Tumor Heterogeneity in Colorectal Cancers Using Heterogeneity Tissue Microarrays.
Stahl PR; Schnellert J; Koop C; Simon R; Marx A; Izbicki JR; Sauter G; Quaas A
Pathol Oncol Res; 2015 Sep; 21(4):1183-9. PubMed ID: 26026893
[TBL] [Abstract][Full Text] [Related]
52. Clinical next generation sequencing to identify actionable aberrations in a phase I program.
Boland GM; Piha-Paul SA; Subbiah V; Routbort M; Herbrich SM; Baggerly K; Patel KP; Brusco L; Horombe C; Naing A; Fu S; Hong DS; Janku F; Johnson A; Broaddus R; Luthra R; Shaw K; Mendelsohn J; Mills GB; Meric-Bernstam F
Oncotarget; 2015 Aug; 6(24):20099-110. PubMed ID: 26015395
[TBL] [Abstract][Full Text] [Related]
53. Clinicopathological analysis of factors related to colorectal tumor perforation: influence of angiogenesis.
Medina-Arana V; Martínez-Riera A; Delgado-Plasencia L; Rodríguez-González D; Bravo-Gutiérrez A; Álvarez-Argüelles H; Alarcó-Hernández A; Salido-Ruiz E; Fernández-Peralta AM; González-Aguilera JJ
Medicine (Baltimore); 2015 Apr; 94(15):e703. PubMed ID: 25881846
[TBL] [Abstract][Full Text] [Related]
54. Clinicopathologic and prognostic relevance of ARID1A protein loss in colorectal cancer.
Wei XL; Wang DS; Xi SY; Wu WJ; Chen DL; Zeng ZL; Wang RY; Huang YX; Jin Y; Wang F; Qiu MZ; Luo HY; Zhang DS; Xu RH
World J Gastroenterol; 2014 Dec; 20(48):18404-12. PubMed ID: 25561809
[TBL] [Abstract][Full Text] [Related]
55. ASPP2 enhances oxaliplatin (L-OHP)-induced colorectal cancer cell apoptosis in a p53-independent manner by inhibiting cell autophagy.
Shi Y; Han Y; Xie F; Wang A; Feng X; Li N; Guo H; Chen D
J Cell Mol Med; 2015 Mar; 19(3):535-43. PubMed ID: 25534115
[TBL] [Abstract][Full Text] [Related]
56. Clinical utility of recombinant adenoviral human p53 gene therapy: current perspectives.
Chen GX; Zhang S; He XH; Liu SY; Ma C; Zou XP
Onco Targets Ther; 2014; 7():1901-9. PubMed ID: 25364261
[TBL] [Abstract][Full Text] [Related]
57. Establishment of new predictive markers for distant recurrence of colorectal cancer using lectin microarray analysis.
Nakajima K; Inomata M; Iha H; Hiratsuka T; Etoh T; Shiraishi N; Kashima K; Kitano S
Cancer Med; 2015 Feb; 4(2):293-302. PubMed ID: 25355679
[TBL] [Abstract][Full Text] [Related]
58. TP53 and PIK3CA gene mutations in adenocarcinoma, squamous cell carcinoma and high-grade intraepithelial neoplasia of the cervix.
Tornesello ML; Annunziata C; Buonaguro L; Losito S; Greggi S; Buonaguro FM
J Transl Med; 2014 Sep; 12():255. PubMed ID: 25220666
[TBL] [Abstract][Full Text] [Related]
59. DNA methylation of apoptosis genes in rectal cancer predicts patient survival and tumor recurrence.
Benard A; Zeestraten EC; Goossens-Beumer IJ; Putter H; van de Velde CJ; Hoon DS; Kuppen PJ
Apoptosis; 2014 Nov; 19(11):1581-93. PubMed ID: 25064172
[TBL] [Abstract][Full Text] [Related]
60. PHF2 histone demethylase acts as a tumor suppressor in association with p53 in cancer.
Lee KH; Park JW; Sung HS; Choi YJ; Kim WH; Lee HS; Chung HJ; Shin HW; Cho CH; Kim TY; Li SH; Youn HD; Kim SJ; Chun YS
Oncogene; 2015 May; 34(22):2897-909. PubMed ID: 25043306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]